AEON+'s logo.
Ticker Symbol: AEON+

AEON Biopharma Inc. - Warrants (28/02/2028)

Exchange: NYSE MKT LLC Currency: USD Asset Type: Warrant CIK:0001837607

Company Profile

we are a nasdaq-listed special purpose acquisition company whose business purpose is to effect a merger or similar business combination with one or more businesses. our acquisition strategy is to identify and complete our initial business combination with a medical technology company in the healthcare industry. our sponsor team consists of chairman/ceo robert palmisano, president vikram malik, cfo oleg grodnensky and chief legal officer david meredith.

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: N/A
Tags: N/A


Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.11
Change: $0.00 ( -2.83%)
Days Range: $0.11 - $0.11
Beta: -
52wk. High: $0.36
52wk. Low: $0.00
Ytd. Change 138.40%
50 Day Moving Average: $0.13
200 Day Moving Average: $0.11
Shares Outstanding: 9200000


Market Cap: 1.2B
PE Ratio: -
EPS (TTM): 0


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A